Skip to content
OpenCapital
Get started

TriSalus Life Sciences, Inc. TLSI EPS (Diluted)

EPS (Diluted) at other companies

Boston Scientific logo
Boston ScientificBSX
$0.90+100%
AngioDynamics logo
AngioDynamicsANGO
-$0.19-72.7%
Delcath Systems logo
Delcath SystemsDCTH
-$0.03-200%
Tactile Systems Technology logo
Tactile Systems TechnologyTCMD
-$0.08+38.5%
LQD
Liquidia CorporationLQDA
$0.52+216%
United Therapeutics logo
United TherapeuticsUTHR
$5.82-12.2%

Other financials

Income statement

See full
Revenue$8.9M-2.9%
Gross profit$7.7M0.0%
Operating income-$8.4M-14.8%
Net income$1.5M+115%

Balance sheet

See full
Cash & equivalents$56.6M+324%
Total debt$33.1M+4.4%
Total equity$12.8M+137%
Total assets$71.0M+148%

Cash flow

See full
Operating cash flow-$6.5M-44.0%
CapEx$141.0K-81.3%
Free cash flow-$6.6M-26.0%

Valuation

See full
Market cap$279.45M+45.1%
Enterprise value$255.97M+29.3%
P/S6.2×+0.9×

Profitability

See full
Gross margin85.1%-0.5pp
Operating margin-62.4%-16.8pp
Net margin-60.9%-13.4pp
FCF margin-45.2%-16.8pp

Returns & leverage

See full
Return on equity253.3%—
Debt / equity2.6×—
Current ratio5.8×+3.6×

Where this comes from

Reported directly by TriSalus Life Sciences, Inc. in its filing.

Tagged under the XBRL concept us-gaap:EarningsPerShareDiluted.

The official record: TriSalus Life Sciences, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about TriSalus Life Sciences, Inc.'s eps (diluted).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is TriSalus Life Sciences, Inc.'s EPS (diluted)?
TriSalus Life Sciences, Inc. (TLSI) reported EPS (diluted) of $0.03 in Q1 2026.
How has TriSalus Life Sciences, Inc.'s EPS (diluted) changed year-over-year?
TriSalus Life Sciences, Inc.'s EPS (diluted) increased by 107.7% year-over-year, from -$0.39 to $0.03.
What is the long-term trend for TriSalus Life Sciences, Inc.'s EPS (diluted)?
Over 4 years (2021 to 2025), TriSalus Life Sciences, Inc.'s EPS (diluted) has grown at a 84.6% compound annual growth rate (CAGR), from $0.15 to -$1.74.
What does EPS (diluted) mean?
Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.